Baystate Wealth Management’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
Other funds holding IDXX
Baystate Wealth Management's IDXX Position: Q4 2023 in Review
Baystate Wealth Management increased its Idexx Laboratories (IDXX) stake by 4.5% in Q4 2023, buying an estimated $6.57K and bringing the position to 322 shares worth $179K. The position accounts for 0.01% of the portfolio, ranked #211.
Baystate Wealth Management first reported a position in IDXX in Q2 2013 and has held it in 30 quarters since. 1,153 funds tracked by Wall St. Rank hold IDXX as of Q4 2023.
- Baystate Wealth Management held 322 shares of Idexx Laboratories worth $179K as of Q4 2023.
- Baystate Wealth Management bought 14 Idexx Laboratories shares in Q4 2023, an estimated $6.57K.
- Idexx Laboratories made up 0.01% of Baystate Wealth Management's portfolio in Q4 2023, its #211 holding.
- Baystate Wealth Management first reported a position in Idexx Laboratories in Q2 2013 and has held it in 30 quarters since.
- 1,153 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2023.
Based on Baystate Wealth Management's 13F filing for Q4 2023, filed 29 Jan 2024.